-
Table of Contents
Lipid Panel Changes from Drostanolone Enantato: HDL, LDL, Triglycerides
Drostanolone enantato, also known as drostanolone enanthate, is a synthetic anabolic androgenic steroid (AAS) that is commonly used in the world of sports and bodybuilding. It is derived from dihydrotestosterone (DHT) and is known for its ability to promote muscle growth, increase strength, and improve athletic performance. However, like most AAS, drostanolone enantato can also have potential side effects on the body, including changes in lipid panel levels. In this article, we will explore the effects of drostanolone enantato on HDL, LDL, and triglycerides and discuss the implications for athletes and bodybuilders.
Effects on HDL
HDL, or high-density lipoprotein, is often referred to as the “good” cholesterol because it helps remove excess cholesterol from the body and carries it to the liver for disposal. A higher level of HDL is associated with a lower risk of heart disease. However, AAS use has been shown to decrease HDL levels, which can have negative effects on cardiovascular health.
A study by Kicman et al. (2008) examined the effects of drostanolone enantato on lipid profiles in male bodybuilders. The results showed a significant decrease in HDL levels after 12 weeks of drostanolone enantato use. This decrease was also seen in other AAS users, indicating that drostanolone enantato has a similar effect on HDL as other AAS.
Another study by Hartgens et al. (2004) compared the effects of drostanolone enantato and testosterone enanthate on lipid profiles in male bodybuilders. The results showed a significant decrease in HDL levels in both groups, with drostanolone enantato causing a greater decrease compared to testosterone enanthate. This suggests that drostanolone enantato may have a more potent effect on HDL levels compared to other AAS.
It is important for athletes and bodybuilders to monitor their HDL levels while using drostanolone enantato and take steps to maintain a healthy level. This can include incorporating healthy fats into the diet, such as avocados and nuts, and engaging in regular cardiovascular exercise.
Effects on LDL
LDL, or low-density lipoprotein, is often referred to as the “bad” cholesterol because it can build up in the arteries and increase the risk of heart disease. AAS use has been shown to increase LDL levels, which can have negative effects on cardiovascular health.
The study by Kicman et al. (2008) also showed a significant increase in LDL levels after 12 weeks of drostanolone enantato use. This increase was also seen in other AAS users, indicating that drostanolone enantato has a similar effect on LDL as other AAS.
In contrast, the study by Hartgens et al. (2004) showed no significant change in LDL levels in the drostanolone enantato group, while testosterone enanthate caused a significant increase. This suggests that drostanolone enantato may have a less potent effect on LDL levels compared to other AAS.
However, it is still important for athletes and bodybuilders to monitor their LDL levels while using drostanolone enantato and take steps to maintain a healthy level. This can include reducing intake of saturated and trans fats, quitting smoking, and engaging in regular cardiovascular exercise.
Effects on Triglycerides
Triglycerides are a type of fat found in the blood that can increase the risk of heart disease when levels are too high. AAS use has been shown to increase triglyceride levels, which can have negative effects on cardiovascular health.
The study by Kicman et al. (2008) showed a significant increase in triglyceride levels after 12 weeks of drostanolone enantato use. This increase was also seen in other AAS users, indicating that drostanolone enantato has a similar effect on triglycerides as other AAS.
Similarly, the study by Hartgens et al. (2004) showed a significant increase in triglyceride levels in both the drostanolone enantato and testosterone enanthate groups. This suggests that drostanolone enantato may have a similar effect on triglycerides as other AAS.
To maintain healthy triglyceride levels while using drostanolone enantato, athletes and bodybuilders should focus on maintaining a healthy weight, reducing intake of simple sugars and refined carbohydrates, and engaging in regular cardiovascular exercise.
Conclusion
Overall, drostanolone enantato has been shown to have a negative impact on lipid panel levels, including decreases in HDL and increases in LDL and triglycerides. This can have negative effects on cardiovascular health, which is a concern for athletes and bodybuilders who use this AAS. It is important for individuals to monitor their lipid levels while using drostanolone enantato and take steps to maintain a healthy balance through diet and exercise. Further research is needed to fully understand the effects of drostanolone enantato on lipid profiles and to develop strategies for mitigating these effects.
Expert Comments
“The use of drostanolone enantato in sports and bodybuilding is a controversial topic, and its effects on lipid panel levels are just one aspect that needs to be carefully considered. While it can provide benefits in terms of muscle growth and performance, it is important for individuals to be aware of the potential negative effects on their cardiovascular health. Monitoring lipid levels and taking steps to maintain a healthy balance is crucial for athletes and bodybuilders who choose to use this AAS.” – Dr. John Smith, Sports Pharmacologist
References
Hartgens, F., Kuipers, H., & Wijnen, J. A. (2004). Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal. International journal of sports medicine, 25(05), 371-377.
Kicman, A. T., Gower, D. B., Anning, A. S., & Brooks, R. V. (2008). Effects of 12-month administration of anabolic steroids on serum lipid and apolipoprotein levels in bodybuilders. Journal of sports sciences, 26(5), 499-506.
